Condition

Acromegaly clinical trials and research

• 10Clinical trials
• 2NIH research projects
• 1New in 30 days
• 23Countries

Newest Acromegaly clinical trials

All recruiting trials (10)

• NTQ6179 tablets first-in-human test in healthy adults

  This phase 1 study tests a single oral dose of NTQ6179 vs placebo in healthy adults to see if it is safe and how the body processes the drug.

  Recruiting Phase 1 Nanjing Chia-tai Tianqing Pharmaceutical · Beijing · NCT07909837

• Test MAR002 for acromegaly in adults on or off medical therapy

  This study tests whether subcutaneous MAR002 is safe and tolerable in adults with acromegaly, compared with a placebo, over 10 weeks.

  Recruiting at 3 sites Phase 2 Marea Therapeutics · Phoenix, Arizona and 2 other locations · NCT07641179

• Octreotide SC Depot in Acromegaly: Real-World Safety and Effectiveness

  This study follows people with acromegaly who are using octreotide subcutaneous depot to see how it works and how safe it is over up to two years in everyday clinical practice.

  Recruiting at 4 sites Camurus AB · Aachen and 6 other locations · NCT07583563

• MAR002 in healthy men

  This trial tests whether a subcutaneous injection of MAR002 is safe and tolerable in healthy men aged 18 to 40.

  Recruiting Phase 1 Marea Therapeutics · Tempe, Arizona · NCT07195175

• Pasireotide LAR and bone health in adults with acromegaly

  This study will test whether switching adults with uncontrolled acromegaly to pasireotide LAR changes bone turnover and the risk of vertebral fractures.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome, RM · NCT07179926

• Assessing Debio 4126 for treating acromegaly in patients on somatostatin analogs

  This study is testing if a new treatment called Debio 4126 can help people with acromegaly who are already on somatostatin analogs keep their IGF-1 levels in check better than a placebo.

  Recruiting at 72 sites Phase 3 Debiopharm International SA · Los Angeles, California and 73 other locations · NCT06930625

• Evaluating the effects of acromegaly on hand and foot dimensions and movement

  This study looks at how acromegaly affects the size and movement of hands and feet in patients to better understand the physical changes caused by the condition.

  Recruiting Istituto Auxologico Italiano · Milan · NCT05964712

• Long-term assessment of acromegaly treatment patterns and outcomes

  This study looks at how different treatments for acromegaly are working for patients in China and what effects they have over time.

  Recruiting Ginkgo Leaf Center for Rare Disorders · Guangzhou, Guangdong · NCT03158090

• Developing a recognition system for acromegaly

  This study is trying to see if a new 3D imaging system can help spot acromegaly earlier by comparing the features of people with the condition to those of healthy adults.

  Recruiting National Taiwan University Hospital · Taipei · NCT03042026

• Identifying genes linked to familial pituitary adenomas

  This study is trying to find out if certain genes are linked to pituitary tumors in families, especially for people with conditions like acromegaly and gigantism.

  Recruiting at 3 sites Barts & The London NHS Trust · Leicester and 2 other locations · NCT00461188

NIH-funded research (2)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• A new antibody treatment for acromegaly

  A novel antibody medicine aims to lower excess growth hormone in adults with acromegaly to help control symptoms and complications.

  NIH research Elixera, INC. · Redwood City, United States · NIH-11182613

• A new antibody treatment for acromegaly

  This study is testing a new treatment for acromegaly that uses a special antibody to help control growth hormone levels, aiming to provide better long-term health for people with this condition.

  NIH research Elixera, INC. · Redwood City, United States · NIH-11008939

Related topics

Quick answers

How many Acromegaly clinical trials are recruiting right now?

10, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 23 countries. The most sites are in Italy (3 trials), United Kingdom (3 trials), United States (3 trials), China (2 trials), Germany (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1: 2, Phase 2: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →